This page highlights funding opportunity announcements related to disaster research response from NIEHS, from other NIH institutes and centers (ICs), and from other federal agencies. This list will change as new funding opportunity announcements are released and others close. See the individual announcement for application due dates.
NIEHS Funding Opportunities
- RFA-ES-23-007: Exploratory Grants for Climate Change and Health Research Center Development (P20 Clinical Trial Optional)
This program will support the development of an innovative research environment to foster and sustain a transdisciplinary program of fundamental and applied research to explore the complex impacts of climate change on health and to develop action-oriented strategies that protect health and build resiliency at the individual, community, national and global levels.
Available Due Dates: May 01, 2023; November 07, 2023
Expiration Date: Nov 8, 2023
- NOT-ES-22-006: Notice of Special Interest: Climate Change and Health
This NOSI will encourage research applications that address the impact of climate change on health and well-being over the life course, including the health implications of climate change in the United States and globally.
First Available Due Date: July 08, 2022
Expiration Date: May 08, 2025
- Mechanism for Time-sensitive Research Opportunities in Environmental Health Sciences (R21 Clinical Trial Not Allowed)
Supports environmental health research in which an unpredictable event provides a limited window of opportunity to collect human biological samples or environmental exposure data. The program aims to understand the consequences of natural and human-caused disasters or emerging public health threats in the U.S. and abroad.
NIH Funding Opportunities
- NIH Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence (U54 – Clinical Trial Optional)
The mission of the NIH CounterACT program is to support research and development of new therapeutics for chemical threats. Chemical threats are toxic chemicals that could be used in a terrorist attack or accidentally released from industrial production, storage, or shipping. They include traditional chemical warfare agents, toxic industrial chemicals, pharmaceutical-based agents, pesticides, and others.
Special Topic: COVID-19
- Rapid Acceleration of Diagnostics for Underserved Populations (RADx-UP)
The National Institutes of Health (NIH) Rapid Acceleration of Diagnostics-Underserved Populations (RADx-UP) aims to understand and alleviate the barriers to COVID-19 testing to ensure that all Americans have access, with a focus on communities most affected by the pandemic. The RADx-UP Coordination and Data Collection Center is managed through a partnership of the Duke Clinical Research Institute, the UNC-Chapel Hill Center for Health Equity Research, and Community-Campus Partnerships for Health.
Related Funding Opportunities
National Science Foundation (NSF)
- NSF Disaster Resilience Research Grants
- NSF Humans, Disasters, and Built Environment Program
- NSF Natural Hazards Center Quick Response Research Program